News | July 23, 2010

Radiotherapy Enhancements Compensate for Chest Motion

July 23, 2010 – A new system for image-guided radiotherapy and radiosurgery was exhibited for the first time earlier this week at the 2010 meeting of the American Association of Physicists in Medicine (AAPM). Varian’s TrueBeam is a fully-integrated system designed to treat moving tumors with a high level of speed and accuracy.

Varian also exhibited its next generation Gated RapidArc radiotherapy technology together with other products for planning and delivering treatments.

TrueBeam incorporates numerous technical innovations that synchronize imaging, patient positioning, motion management and treatment delivery during radiotherapy or radiosurgery. The system delivers dose more than twice as fast as other linear accelerators and streamlines workflow to reduce the number of steps needed to complete a treatment.

With Gated RapidArc it is possible to compensate for breathing-related tumor motion during RapidArc treatments, giving clinicians new options for treating their lung cancer patients. The new Arc Geometry Tool within the Eclipse treatment planning system offers clinicians many more tumor-targeting options by calculating plans that use sophisticated combinations of partial arcs, multiple arcs and changes in the position of the patient couch.

For more information: www.varian.com

Related Content

Merit Medical Completes Acquisition of Cianna Medical
News | Women's Health | November 14, 2018
Disposable device manufacturer Merit Medical Systems Inc. announced the closing of a definitive merger agreement to...
Videos | ASTRO | November 08, 2018
ITN Editor Dave Fornell took a tour of some of the most innovative technologies on display on the expo floor at the 
The Fujifilm FCT Embrace CT System displayed for the first time at ASTRO 2018.
360 Photos | 360 View Photos | November 07, 2018
Fujifilm's first FDA-cleared compu...
This is the Siemens Magnetom Sola RT edition 1.5T MRI system optimized for radiation therapy displayed for the first time since gaining FDA clearance in 2018. It was displayed at the American Society for Radiotherapy and Oncology (ASTRO) 2018 annual meeting. Read more about this system at ASTRO 2018. #ASTRO18 #ASTRO2018
360 Photos | 360 View Photos | November 07, 2018
This is the Siemens Magnetom Sola RT edition 1.5T MRI system optimized for...
GE Healthcare Discovery RF Gen 2 system displayed at ASTRO 2018. It is a dedicated computed tomography (CT) scanner for radiation oncology
360 Photos | 360 View Photos | November 07, 2018
This is the GE Healthcare Discovery RF Gen 2 system displayed at the ...
Proton Therapy for Pediatric Brain Tumors Has Favorable Cognitive Outcomes
News | Proton Therapy | November 06, 2018
Proton therapy treatment for pediatric brain tumor patients is associated with better neurocognitive outcomes compared...
The patient’s wife changes the Optune array. Clinical trials indicate that the electrical fields emitted by Optune have the potential to lengthen the lives of patients with glioblastoma.

The patient’s wife changes the Optune array. Clinical trials indicate that the electrical fields emitted by Optune have the potential to lengthen the lives of patients with glioblastoma.

Feature | Radiation Oncology | November 06, 2018 | By Greg Freiherr
Approximately 11,000 professionals attended the four-day meeting of the...